Wu Guanjiang became wealthy as an early owner and executive of vaccine maker Zhifei Biological, joining the 2002 acquisition that created the modern company and retaining a valuable equity stake. [1][2][3]
He joined the transaction that created modern Zhifei
Chinese financial press accounts identify Wu as one of the partners who joined Jiang Rensheng in 2002 to acquire Chongqing Jinxin Biological Products and rename it Chongqing Zhifei Biological Products. That transaction became the foundation of the later listed vaccine company. [1][2]
Contemporary executive biographies describe Wu as having worked as a manager before serving as Zhifei's vice chairman and deputy general manager. The available record therefore places him in operating and ownership roles during the company's early growth rather than as a later passive investor. [2][3]
The reviewed sources do not identify an inherited business platform as the source of Wu's stake. They instead connect his wealth to participation in the acquisition, management and ownership of Zhifei, though the public biographical record is less detailed than it is for the company's chairman. [1][2]
A large early equity stake turned into substantial wealth
Zhifei listed on Shenzhen's ChiNext market in 2010, turning its early owners into major public-company shareholders. A 2012 China Securities Journal report described Wu as a founding-era executive and documented substantial sales of shares after the listing. [2]
The company's 2021 annual report still listed Wu among its largest shareholders, with more than 17 million shares at year end after significant reductions during the year. His fortune is best understood as wealth created through an early entrepreneurial ownership position, with medium confidence because public sources give only limited detail on his pre-Zhifei finances. [3][1]
Sources for background
Sources reviewed Oct 15, 2026.
- Zhifei Biological: independent products plus agency distribution · China Securities Journal · Oct 12, 2018
- Wu Guanjiang becomes a major seller of Chongqing-listed shares · China Securities Journal · Jul 18, 2012
- 2021 Annual Report · Chongqing Zhifei Biological Products · Apr 28, 2022
Comparable Healthcare billionaires
Similar Healthcare billionaires by estimated net worth.
